National multipl sclerosis. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy16

Spinal Cord Brain Myelin Sheath Motor Neurons Oligodendroglia Central Nervous System Skin Nerve Fibers, Myelinated Axons Microglia Astrocytes Cells, Cultured T-Lymphocytes Cerebrospinal Fluid Inclusion Bodies Optic Nerve

Organisms3

Mice, Transgenic Mice, Inbred C57BL Theilovirus

Diseases50

Multiple Sclerosis Sclerosis Amyotrophic Lateral Sclerosis Tuberous Sclerosis Scleroderma, Systemic Multiple Sclerosis, Chronic Progressive Encephalomyelitis, Autoimmune, Experimental Scleroderma, Diffuse Demyelinating Diseases Diffuse Cerebral Sclerosis of Schilder Optic Neuritis Scleroderma, Limited Disease Progression Motor Neuron Disease Raynaud Disease Angiomyolipoma Peritoneal Fibrosis Epilepsy, Temporal Lobe Disease Models, Animal Scleroderma, Localized Atrophy Neuromyelitis Optica Rhabdomyoma Lymphangioleiomyomatosis Nervous System Diseases Recurrence Nerve Degeneration Chronic Disease Autoimmune Diseases Neoplasms Encephalomyelitis, Acute Disseminated Neurodegenerative Diseases Glomerulosclerosis, Focal Segmental Genetic Predisposition to Disease Demyelinating Autoimmune Diseases, CNS Fatigue Epilepsy Skin Ulcer Frontotemporal Dementia Acute Disease Monckeberg Medial Calcific Sclerosis Brain Diseases Stroke Wounds and Injuries Fibrosis Remission, Spontaneous Frontotemporal Lobar Degeneration Pulmonary Fibrosis Inflammation Facial Neoplasms

Chemicals and Drugs26

Myelin Basic Protein Superoxide Dismutase Oligoclonal Bands Interferon-beta Myelin-Oligodendrocyte Glycoprotein Myelin Proteins Myelin-Associated Glycoprotein Autoantibodies Immunologic Factors Myelin Proteolipid Protein RNA-Binding Protein FUS Biological Markers HLA-DR2 Antigen Tumor Suppressor Proteins Cuprizone Immunosuppressive Agents Propylene Glycols HLA-DRB1 Chains Immunoglobulin G Cerebrospinal Fluid Proteins Neurofilament Proteins TOR Serine-Threonine Kinases Methylprednisolone Riluzole Autoantigens HLA-DR Antigens

Analytical, Diagnostic and Therapeutic Techniques and Equipment57

Encephalomyelitis, Autoimmune, Experimental Magnetic Resonance Imaging Health Surveys Risk Factors Prevalence Cross-Sectional Studies Data Collection Nutrition Surveys Disability Evaluation Registries Cohort Studies Severity of Illness Index Retrospective Studies Questionnaires Population Surveillance Treatment Outcome Incidence Case-Control Studies Follow-Up Studies Disease Models, Animal Health Care Surveys Prospective Studies Logistic Models Reproducibility of Results Longitudinal Studies Risk Assessment Odds Ratio Regression Analysis Multivariate Analysis Sensitivity and Specificity Statistics, Nonparametric Mass Screening Clinical Trials as Topic Pilot Projects Neurologic Examination Prognosis Risk Program Evaluation Interviews as Topic Hospitalization Predictive Value of Tests Analysis of Variance Research Design Cause of Death Chi-Square Distribution Statistics as Topic Mortality Reference Values Immunohistochemistry Epidemiologic Methods Confidence Intervals Autopsy Linear Models Psychosurgery Enzyme-Linked Immunosorbent Assay Survival Analysis Activities of Daily Living

Psychiatry and Psychology8

Smoking Frontotemporal Dementia Cognition Disorders Psychosurgery Frontotemporal Lobar Degeneration Health Knowledge, Attitudes, Practice Mental Disorders Neuropsychological Tests

Phenomena and Processes13

Time Factors Odds Ratio Pregnancy Sensitivity and Specificity DNA Repeat Expansion Risk Genetic Predisposition to Disease Mutation Phenotype Chi-Square Distribution Genotype Autoimmunity Remission, Spontaneous

Disciplines and Occupations8

Research Public Health Biomedical Research Outcome Assessment (Health Care)Research Design Statistics as Topic Health Services Research Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena24

National Institutes of Health (U.S.)National Library of Medicine (U.S.)National Cancer Institute (U.S.)National Center for Health Statistics (U.S.)National Heart, Lung, and Blood Institute (U.S.)National Institute for Occupational Safety and Health (U.S.)Health Policy Demography International Cooperation Health Status National Institute on Aging (U.S.)National Institute of Neurological Disorders and Stroke Government Agencies Centers for Disease Control and Prevention (U.S.)Quality of Life Child Welfare Cost of Illness Autopsy Forecasting Internationality Public Policy Social Class Activities of Daily Living Emigration and Immigration

Humanities2

History, 20th Century Quality of Life

Information Science12

National Library of Medicine (U.S.)Prevalence Data Collection Registries Questionnaires Incidence Databases, Factual Interviews as Topic Cause of Death Mortality Image Processing, Computer-Assisted Databases as Topic

Named Groups7

Infant, Newborn European Continental Ancestry Group Ethnic Groups Disabled Persons African Americans Hispanic Americans Continental Population Groups

Health Care98

National Institutes of Health (U.S.)National Health Programs National Library of Medicine (U.S.)National Cancer Institute (U.S.)National Center for Health Statistics (U.S.)Health Surveys Risk Factors Prevalence National Heart, Lung, and Blood Institute (U.S.)Cross-Sectional Studies Data Collection Nutrition Surveys Registries Cohort Studies Age Factors Severity of Illness Index Retrospective Studies Questionnaires Population Surveillance Treatment Outcome Incidence Case-Control Studies National Academy of Sciences (U.S.)Follow-Up Studies Sex Factors Health Care Surveys National Institute for Occupational Safety and Health (U.S.)Age of Onset Prospective Studies Logistic Models Reproducibility of Results Health Policy Longitudinal Studies State Medicine Practice Guidelines as Topic Demography Risk Assessment Odds Ratio Ethnic Groups Regression Analysis Health Services Accessibility Multivariate Analysis Sensitivity and Specificity Research Support as Topic Statistics, Nonparametric Mass Screening Physician's Practice Patterns Clinical Trials as Topic Health Status Comorbidity National Institute on Aging (U.S.)Guideline Adherence Public Health National Institute of Neurological Disorders and Stroke Government Agencies Financing, Government Pilot Projects Guidelines as Topic Centers for Disease Control and Prevention (U.S.)Risk Program Evaluation Interviews as Topic Hospitalization Academies and Institutes Outcome Assessment (Health Care)Cost-Benefit Analysis Quality Assurance, Health Care Predictive Value of Tests Delivery of Health Care Health Expenditures Health Care Costs Educational Status Analysis of Variance Societies, Medical Cause of Death Chi-Square Distribution Statistics as Topic Health Services Research Mortality Cost of Illness Epidemiologic Methods Confidence Intervals Quality of Health Care Linear Models Income Hospitals Policy Making Public Policy Health Knowledge, Attitudes, Practice Insurance, Health World Health Organization Health Services Needs and Demand Social Class Survival Analysis Program Development Health Promotion Activities of Daily Living Emigration and Immigration

Geographicals20

United States Great Britain Canada England France Denmark Europe Italy Australia Sweden Wales Wyoming Taiwan Republic of Korea Japan Ireland Guam India Brazil Scotland

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Multiple Sclerosis Sclerosis Amyotrophic Lateral Sclerosis Tuberous Sclerosis Scleroderma, Systemic Multiple Sclerosis, Chronic Progressive National Institutes of Health (U.S.)United States National Health Programs Encephalomyelitis, Autoimmune, Experimental Scleroderma, Diffuse National Library of Medicine (U.S.)Magnetic Resonance Imaging National Cancer Institute (U.S.)Demyelinating Diseases Diffuse Cerebral Sclerosis of Schilder National Center for Health Statistics (U.S.)Spinal Cord Brain Optic Neuritis Health Surveys Scleroderma, Limited Risk Factors Prevalence Myelin Basic Protein National Heart, Lung, and Blood Institute (U.S.)Great Britain Cross-Sectional Studies Disease Progression Motor Neuron Disease Superoxide Dismutase Data Collection Time Factors Oligoclonal Bands Nutrition Surveys Interferon-beta Disability Evaluation Myelin Sheath Registries Cohort Studies Age Factors Severity of Illness Index Retrospective Studies Questionnaires Population Surveillance Treatment Outcome Myelin-Oligodendrocyte Glycoprotein Incidence Raynaud Disease Case-Control Studies Angiomyolipoma Peritoneal Fibrosis National Academy of Sciences (U.S.)Epilepsy, Temporal Lobe Follow-Up Studies Disease Models, Animal Scleroderma, Localized Sex Factors Health Care Surveys Motor Neurons Atrophy Databases, Factual National Institute for Occupational Safety and Health (U.S.)Age of Onset Myelin Proteins Oligodendroglia Neuromyelitis Optica Infant, Newborn Prospective Studies Myelin-Associated Glycoprotein Logistic Models Reproducibility of Results Health Policy Central Nervous System Longitudinal Studies Canada State Medicine Autoantibodies Immunologic Factors England Practice Guidelines as Topic Myelin Proteolipid Protein Rhabdomyoma Demography RNA-Binding Protein FUS Risk Assessment Lymphangioleiomyomatosis European Continental Ancestry Group France Biological Markers Nervous System Diseases Odds Ratio Skin Recurrence Pregnancy Mice, Transgenic Denmark Nerve Fibers, Myelinated Europe Nerve Degeneration

No FAQ available that match "national multipl sclerosis"